Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), is pleased to announce that coverage for Dexcom G6 ...

MADRID-- (BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM), announced today the Dexcom G6 CGM System has received the CE Mark for use during pregnancy ...

DexCom, Inc. announced today the Dexcom G6 Continuous Glucose Monitoring System is now available at Veterans Affairs pharmacies, improving access to CGM and empowering veterans with diabetes to ...

Spanish-speaking patients can opt to use the Dexcom G6 app in their preferred language, eliminating a language barrier for optimal care.

SAN DIEGO& ACTON, Mass.---- DexCom, Inc. and Insulet Corporation, have announced a global commercialization agreement to combine current and future Dexcom continuous glucose monitoring systems ...

Dexcom G6 users will now be able to integrate their continuous glucose monitor to the Livongo platform for more personalized insights and coaching.

Dexcom has received approval in Europe extending the use of its wearable continuous glucose monitor (CGM) to pregnant women across Type 1, Type 2 and gestational diabetes.

Data from Dexcom CGMs will be integrated into FriskaAi and will be monitored by AI-powered algorithms that alert patients ...

Dexcom, the San Diego-based maker of continual glucose monitors for diabetes patients and pre-diabetics, announced Wednesday ...

DexCom, Inc. (DXCM), headquartered in San Diego, California, is a global leader in the development and manufacturing of ...

The Australian government has expanded the subsidised access to the latest generation of Dexcom's continuous glucose monitoring device, Dexcom G6, for diabetic Australians. This comes as the previous ...